Eventide Asset Management’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
SFCM
Eventide Asset Management's MTRI Position: Q3 2026 in Review
Eventide Asset Management opened a new position in Mentari Therapeutics, Inc. Common Stock (MTRI) in Q3 2026: 435,450 shares worth $5.53M. The stake represents 0.08% of the portfolio and ranks #180 among its holdings.
16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.
- Eventide Asset Management held 435,450 shares of Mentari Therapeutics, Inc. Common Stock worth $5.53M as of Q3 2026.
- Mentari Therapeutics, Inc. Common Stock was a new Eventide Asset Management position in Q3 2026.
- Mentari Therapeutics, Inc. Common Stock made up 0.08% of Eventide Asset Management's portfolio in Q3 2026, its #180 holding.
- 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.
Based on Eventide Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.